LAUREN JILL BIRKINSHAW NP
Prescription History 1750859310
Nurse Practitioner - Family in Lake Forest, CA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for LAUREN JILL BIRKINSHAW NP, an active Family specialist practicing in Lake Forest, CA. Our medical registry currently tracks 5 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 84 documented patient claims. Among these therapy options, the most frequently utilized medication is Albuterol Sulfate Hfa, which accounts for 22 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Claims | 30-Day Fills | Days Supply | Cost / Claim | Utilization vs CA Avg |
|---|---|---|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 22 | 22.1 | 562 | $22.58▼ below CA avg | ▼ Below Avg. |
Utilization: claims vs the average CA prescriber Averages are among CA prescribers of this medication. Utilization reflects practice size as well as clinical preference. Cost per claim: this provider vs the CA average This provider's average cost per claim is below the CA average for this medication. 22.1 30-Day Fills 562 Days Supply About Albuterol Sulfate Hfa: Albuterol (also known as salbutamol) is used to treat wheezing and shortness of breath caused by breathing problems such as asthma. Show more ▾ It is a quick-relief medication. Albuterol belongs to a class of drugs known as bronchodilators. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol. | |||||
| Paxlovid (Eua)Nirmatrelvir/Ritonavir | 19 | 19.0 | 95 | $12.61 | ≈ Typical |
Utilization: claims vs the average CA prescriber Averages are among CA prescribers of this medication. Utilization reflects practice size as well as clinical preference. Cost per claim: this provider vs the CA average Gross Part D cost per claim; not the patient's out-of-pocket price. 19.0 30-Day Fills 95 Days Supply About Paxlovid (Eua): The combination of nirmatrelvir tablets and ritonavir tablets is a product that the FDA is allowing to be given for emergency use to treat COVID-19. Show more ▾ The product is also approved to be used in Canada to treat COVID-19. It is used by people who have recently tested positive for coronavirus, have had mild to moderate symptoms for no more than 5 days and are not hospitalized. To receive this product you must also be at high risk for COVID-19 complications due to older age, obesity, or ongoing medical conditions (such as lung or heart disease or diabetes, among others). Talk to your doctor about the risks and benefits of treatment with nirmatrelvir and ritonavir. Nirmatrelvir is a SARS-CoV-2 main protease inhibitor. It works by preventing the growth of the virus that causes COVID-19. Ritonavir increases (boosts) the levels of nirmatrelvir. This helps nirmatrelvir work better. More information about nirmatrelvir and ritonavir is available from the FDA Fact Sheet for Patients, Parents, and Caregivers for Emergency Use and from the Health Canada Patient Medication Information sheet. There is limited information about how safe and effective the combination of nirmatrelvir and ritonavir is for treating COVID-19. Study results show that nirmatrelvir and ritonavir may help people who have recently tested positive for coronavirus stay out of the hospital. This product is not for use by people who are hospitalized due to COVID-19. The information in this document reflects emerging data, which is evolving and subject to reassessment. Users should be aware of these considerations in their review of nirmatrelvir and ritonavir, and it is always the responsibility of treating practitioners to exercise independent judgement in making care decisions. | |||||
| Lagevrio (Eua)Molnupiravir | 18 | 18.0 | 90 | $10.75 | ≈ Typical |
Utilization: claims vs the average CA prescriber Averages are among CA prescribers of this medication. Utilization reflects practice size as well as clinical preference. Cost per claim: this provider vs the CA average Gross Part D cost per claim; not the patient's out-of-pocket price. 18.0 30-Day Fills 90 Days Supply About Lagevrio (Eua): Molnupiravir is a product that the FDA is allowing to be given for emergency use to treat COVID-19. Show more ▾ It is used by adults 18 years of age and older who have recently tested positive for coronavirus, have had mild to moderate symptoms for no more than 5 days and are not hospitalized. To receive this product you must also be at high risk for COVID-19 complications due to older age, obesity, or ongoing medical conditions (such as lung or heart disease or diabetes, among others). Talk to your doctor about the risks and benefits of treatment with molnupiravir. Molnupiravir works by preventing the growth of the virus that causes COVID-19. More information about molnupiravir is available from the FDA Fact Sheet for Patients, Parents, and Caregivers for Emergency Use. There is limited information about how safe and effective molnupiravir is for treating COVID-19. Study results show that molnupiravir may help people who have recently tested positive for coronavirus stay out of the hospital. This product is not for use by people who are hospitalized due to COVID-19. The information in this document reflects emerging data, which is evolving and subject to reassessment. Users should be aware of these considerations in their review of molnupiravir, and it is always the responsibility of treating practitioners to exercise independent judgement in making care decisions. | |||||
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 13 | 13.0 | 83 | $14.26▼ below CA avg | ▼ Below Avg. |
Utilization: claims vs the average CA prescriber Averages are among CA prescribers of this medication. Utilization reflects practice size as well as clinical preference. Cost per claim: this provider vs the CA average This provider's average cost per claim is below the CA average for this medication. 13.0 30-Day Fills 83 Days Supply About Nitrofurantoin Mono-Macro: This medication is an antibiotic used to treat bladder infections (acute cystitis). Show more ▾ It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. This medication should not be used in infants younger than 1 month old (see also Precautions section). This drug should not be used to treat infections outside the bladder (including kidney infections such as pyelonephritis or perinephric abscesses). | |||||
| Amoxicillin | 12 | 12.0 | 62 | $4.88▼ below CA avg | ▼ Below Avg. |
Utilization: claims vs the average CA prescriber Averages are among CA prescribers of this medication. Utilization reflects practice size as well as clinical preference. Cost per claim: this provider vs the CA average This provider's average cost per claim is below the CA average for this medication. 12.0 30-Day Fills 62 Days Supply About Amoxicillin: Amoxicillin is used to treat a wide variety of bacterial infections. Show more ▾ This medication is a penicillin-type antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. Amoxicillin is also used with other medications to treat stomach/intestinal ulcers caused by the bacteria H. pylori and to prevent the ulcers from returning. A broad-spectrum semisynthetic antibiotic similar to AMPICILLIN except that its resistance to gastric acid permits higher serum levels with oral administration. | |||||
About this data. The prescription history for LAUREN JILL BIRKINSHAW NP is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Family prescribing approach at this Lake Forest, CA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among CA prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.